Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06463002

Ambulatory Blood Pressure Control and Cognition in Patients With Obstructive Sleep Apnea (AMPLE)

Ambulatory Blood Pressure Control and Cognition in Patients With Obstructive Sleep Apnea

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
22 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To compare the blood pressure control and cognitive responses of three groups of patients: those diagnosed with Obstructive Sleep Apnea (OSA) and treated with Continuous Positive Airway Pressure (CPAP) for at least six months, those diagnosed with OSA but not treated, and those without OSA.

Detailed description

This study is designed as an observational, cross-sectional investigation at the National University Hospital and Alexandra Hospital. The research aims to enroll 50 eligible patients in each of the three groups (OSA treated, OSA untreated, and non-OSA, totaling 150 participants). The recruited participants will undergo ambulatory blood pressure monitoring (ABPM) and the Montreal Cognitive Assessment (MoCA). ABPM is a widely used, noninvasive method to determine patients' blood pressure control. MoCA is a widely used screening tool designed to assess cognitive function and detect mild cognitive impairment or early signs of dementia. The MoCA evaluates various cognitive domains, including attention, memory, language, visuospatial abilities, executive functions, and orientation. It consists of a series of tasks and questions that assess different aspects of cognitive functioning, such as drawing specific shapes, recalling words or numbers, and performing simple calculations. A trained healthcare professional will administer the digital version of the MoCA, which usually takes less than 30 minutes to complete. The MoCA has been validated for use in diverse populations and has shown good sensitivity in detecting mild cognitive impairment. The maximum score on the MoCA is 30. Lower scores may indicate potential cognitive impairment.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAmbulatory blood pressure monitoring and Montreal Cognitive AssessmentNoninvasive tests to assess blood pressure control and cognition

Timeline

Start date
2024-07-01
Primary completion
2025-06-01
Completion
2025-09-01
First posted
2024-06-17
Last updated
2024-06-20

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT06463002. Inclusion in this directory is not an endorsement.